title: CT-determined body composition changes with recombinant human growth hormone treatment to adults with growth hormone deficiency.
authors.affiliation: Department of Medicine, University of Göteborg, Sahlgrenska Hospital, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Lönn
authors.forename: H
authors.initials: H
authors.lastname: Kvist
authors.forename: U
authors.initials: U
authors.lastname: Grangård
authors.forename: B A
authors.initials: BA
authors.lastname: Bengtsson
authors.forename: L
authors.initials: L
authors.lastname: Sjöström
mesh_terms: D000273:Adipose Tissue / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D000328:Adult; D001823:Body Composition / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D013006:Growth Hormone / Q000172:deficiency* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009132:Muscles / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D010900:Pituitary Diseases / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D011994:Recombinant Proteins / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D011994:Recombinant Proteins; D013006:Growth Hormone